← Back to Search

Neurostimulation

Neurostimulation for Autism Spectrum Disorder

N/A
Waitlist Available
Research Sponsored by Christiana Care Health Services
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
Children with a known diagnosis of seizures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and 5 weeks of rtms
Awards & highlights

Summary

This trial will test whether transcranial direct current stimulation (tDCS) can help people with ASD by improving social cognition and communication skills.

Who is the study for?
This trial is for individuals who meet the criteria for Autism Spectrum Disorder (ASD) as per the DSM-V and confirmed by GADS, with an ability to understand and cooperate during procedures. It excludes those with severe anxiety or contact avoidance, a history of seizures, metallic implants in head/neck, or pregnant women.Check my eligibility
What is being tested?
The study explores Trans Cranial Magnetic Stimulation (TMS) as a neurostimulation method to improve social interaction and cognitive functions in people with ASD. The aim is to find an effective treatment beyond current medications that only address some behavioral issues.See study design
What are the potential side effects?
While not explicitly stated here, TMS can sometimes cause discomfort at the stimulation site, headache, lightheadedness, or tingling sensations. Rarely it might induce seizures or affect hearing if proper ear protection isn't used.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My child has been diagnosed with seizures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and 5 weeks of rtms
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and 5 weeks of rtms for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The effects of rTMS on reciprocal rigid patterns of behavior
The effects of rTMS on reciprocal social cognition
Secondary outcome measures
The effect of rTMS on verbal fluency
The effects of rTMS on executive function

Trial Design

2Treatment groups
Active Control
Group I: right IPL stimulationActive Control1 Intervention
half of the subjects will receive TMS on the right inferior parietal lobule.
Group II: left IPL stimulationActive Control1 Intervention
half of the subjects will receive TMS on the left inferior parietal lobule.

Find a Location

Who is running the clinical trial?

Christiana Care Health ServicesLead Sponsor
116 Previous Clinical Trials
107,497 Total Patients Enrolled
Dupont Applied BiosciencesIndustry Sponsor
11 Previous Clinical Trials
2,854 Total Patients Enrolled

Media Library

Trans Cranial Magnetic Stimulation (Neurostimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05371912 — N/A
Autism Spectrum Disorder Research Study Groups: right IPL stimulation, left IPL stimulation
Autism Spectrum Disorder Clinical Trial 2023: Trans Cranial Magnetic Stimulation Highlights & Side Effects. Trial Name: NCT05371912 — N/A
Trans Cranial Magnetic Stimulation (Neurostimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05371912 — N/A
~9 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top